Through economic and value chain analysis, this article aims at depicting some of the specific transfer pricing issues in an industry that has generated a substantial level of tax controversy over the last decades: the pharmaceutical industry.
Through economic and value chain analysis, this article aims at depicting some of the specific transfer pricing issues in an industry that has generated a substantial level of tax controversy over the last decades: the pharmaceutical industry.